Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|April 25, 2022
OnabotulinumtoxinA Reduces Health Resource Utilization in Chronic Migraine: PREDICT StudyWerner J Becker, Guy Boudreau, Ian Finkelstein, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|July 5, 2021
OnabotulinumtoxinA Improves Quality of Life in Chronic Migraine: The PREDICT StudyGuy Boudreau, Ian Finkelstein, Corrie Graboski, et al.
Cephalalgia : an International Journal of Headache|August 28, 2025
Effectiveness and tolerability of atogepant as preventive treatment in resistant individuals with chronic migraine: Six-month real-world evidenceAntonio Russo, Marcello Silvestro, Ian Finkelstein, et al.
Cephalalgia : an International Journal of Headache|December 2, 2025
Combination preventive therapy with onabotulinumtoxinA and atogepant for chronic migraine: A 24-week, prospective, real-world evaluation (SYNERGY study)Luigi Francesco Iannone, Marina Romozzi, Antonio Russo, et al.
Pageof 1